Spots Global Cancer Trial Database for radiation therapy (rt)
Every month we try and update this database with for radiation therapy (rt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma | NCT00004123 | Sarcoma | Doxorubicin hyd... Conventional su... Intraoperative ... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Irradiation for Stage I Breast Cancer | NCT05464667 | Breast Cancer | Radiation Thera... | 50 Years - | University of Pittsburgh | |
| Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | NCT02768558 | Non-Small Cell ... | Radiation Thera... Cisplatin Etoposide Nivolumab Placebo | 18 Years - | RTOG Foundation, Inc. | |
| Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers | NCT04221893 | Stage IV Esopha... Stage IV Esopha... Stage IV Gastri... Stage IV Adenoc... Stage IVA Esoph... Stage IVA Esoph... Stage IVA Gastr... Stage IVA Adeno... Stage IVB Esoph... Stage IVB Esoph... Stage IVB Gastr... Stage IVB Gastr... Metastatic Anal... Metastatic Colo... Metastatic Esop... Metastatic Gast... Metastatic Gast... Metastatic Hepa... Metastatic Mali... Metastatic Smal... Pancreatobiliar... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage IV Anal C... Stage IV Colore... Stage IV Hepato... Stage IVA Color... Stage IVA Hepat... Stage IVB Color... Stage IVB Hepat... Stage IVC Color... | Radiation Thera... | 18 Years - | University of California, San Francisco | |
| Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics | NCT02297230 | Breast Cancer | Radiation Thera... Capecitabine Trastuzumab Paclitaxel | 18 Years - 90 Years | NYU Langone Health | |
| Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00004109 | Sarcoma | Doxorubicin Hyd... Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation | NCT03437161 | Breast Cancer | Radiation Thera... | 18 Years - | NYU Langone Health | |
| Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer | NCT00578071 | Cancer of the E... | Panitumumab Capecitabine Oxaliplatin Radiation Thera... | 18 Years - 82 Years | Duke University | |
| Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma | NCT03367715 | MGMT-unmethylat... GBM | Nivolumab Ipilimumab Radiation Thera... | 18 Years - 100 Years | NYU Langone Health | |
| Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer With Homologous Recombination Deficiency That Has Spread to the Liver | NCT05182112 | Pancreatic Canc... | Whole liver irr... Gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Preoperative Irradiation for Stage I Breast Cancer | NCT05464667 | Breast Cancer | Radiation Thera... | 50 Years - | University of Pittsburgh | |
| Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | NCT02768558 | Non-Small Cell ... | Radiation Thera... Cisplatin Etoposide Nivolumab Placebo | 18 Years - | RTOG Foundation, Inc. | |
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy | NCT03534050 | Glioma of Brain | postoperative a... | 20 Years - 84 Years | Chang Gung Memorial Hospital | |
| A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation | NCT03437161 | Breast Cancer | Radiation Thera... | 18 Years - | NYU Langone Health | |
| Preoperative Irradiation for Stage I Breast Cancer | NCT05464667 | Breast Cancer | Radiation Thera... | 50 Years - | University of Pittsburgh | |
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy | NCT03534050 | Glioma of Brain | postoperative a... | 20 Years - 84 Years | Chang Gung Memorial Hospital | |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer | NCT02318771 | Head and Neck S... Metastatic Rena... Recurrent Head ... Recurrent Lung ... Recurrent Renal... Recurrent Skin ... Stage III Renal... Stage IV Lung C... Stage IV Skin M... | Radiation Thera... MK-3475 | 18 Years - | Thomas Jefferson University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
